Fatigue is a common symptom in multiple sclerosis (MS). As fatigue includes a variety of aspects, its treatment is best approached in a multidisciplinary fashion that includes nonpharmacological interventions and medications. In individuals with mild fatigue non-pharmacological treatment including yoga, aerobic exercises, cooling therapy and energy conservation techniques might be considered. Several pharmacological treatments for patients with significant fatigue have proved to be effective. Among these agents, amantadine and aminopyridines are the most frequently used. More recently also aspirin and carnitine have been used to treat MS fatigue but they need to be confirmed in larger studies. © Springer-Verlag Italia 2006.

Treatment of multiple sclerosis-related fatigue: pharmacological and non-pharmacological approaches / Pozzilli, Carlo; Sbardella, E.; De Giglio, L.; Tomassini, V.. - In: NEUROLOGICAL SCIENCES. - ISSN 1590-1874. - 27:SUPPL. 4(2006), pp. s297-s299. [10.1007/s10072-006-0644-5]

Treatment of multiple sclerosis-related fatigue: pharmacological and non-pharmacological approaches

Pozzilli, Carlo;De Giglio, L.;TOMASSINI, VALENTINA
2006

Abstract

Fatigue is a common symptom in multiple sclerosis (MS). As fatigue includes a variety of aspects, its treatment is best approached in a multidisciplinary fashion that includes nonpharmacological interventions and medications. In individuals with mild fatigue non-pharmacological treatment including yoga, aerobic exercises, cooling therapy and energy conservation techniques might be considered. Several pharmacological treatments for patients with significant fatigue have proved to be effective. Among these agents, amantadine and aminopyridines are the most frequently used. More recently also aspirin and carnitine have been used to treat MS fatigue but they need to be confirmed in larger studies. © Springer-Verlag Italia 2006.
File allegati a questo prodotto
File Dimensione Formato  
Pozzilli_sclerosis-related-fatigue_2006.pdf

solo gestori archivio

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 34.43 kB
Formato Adobe PDF
34.43 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11573/1150380
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 3
  • ???jsp.display-item.citation.isi??? 3
social impact